MedPath

Sprintec

Sprintec (norgestimate and ethinylestradiol tablets)Rx only

Approved
Approval ID

e2f5ed4f-dd97-4dda-83d1-f8edd8786c0e

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 17, 2011

Manufacturers
FDA

Rebel Distributors Corp

DUNS: 118802834

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Norgestimate and Ethinyl Estradiol

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code21695-769
Application NumberANDA075804
Product Classification
M
Marketing Category
C73584
G
Generic Name
Norgestimate and Ethinyl Estradiol
Product Specifications
Effective DateOctober 27, 2009
FDA Product Classification

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Sprintec - FDA Drug Approval Details